• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
PTX 2.08% 4.9¢

PRESCIENT THERAPEUTICS LIMITED

Prescient Therapeutics Limited is an Australia-based clinical-stage oncology company. The... Prescient Therapeutics Limited is an Australia-based clinical-stage oncology company. The Company is developing personalized medicine approaches to cancer, including targeted and cellular therapies. Its product pipeline includes PTX-100, PTX-200, OmniCAR, CellPryme-M and CellPryme-A. PTX-100 has completed Phase Ib expansion cohort study in relapsed and refractory T cell lymphomas. PTX-200 is a PH domain inhibitor that inhibits a tumor survival pathway, Akt. OmniCAR is a universal immune receptor platform being developed to enable controllable T-cell activity and multi-antigen targeting with a single-cell product. CellPryme-M technology enhances adoptive cell therapy performance by shifting T and NK cells towards a central memory phenotype, improving persistence, and increasing the ability to find and penetrate tumors. CellPryme-A is an adjuvant therapy designed to be administered to patients alongside cellular immunotherapy to help them overcome a suppressive tumor microenvironment.More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
PTX 14/02/25 12 5.8K
14/02/25 Last post  Shellbell Comments Created with Sketch.  12  Views Created with Sketch.  5.8K 
PTX 31/01/25 0 471
31/01/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  471 
PTX 24/01/25 32 13K
TRENDING NEWS
NEWS
15 Feb 2025
24/01/25 Last post  Shellbell Comments Created with Sketch.  32  Views Created with Sketch.  13K 
PTX 23/01/25 63 35K
23/01/25 Last post  Un1qu3Nam3 Comments Created with Sketch.  63  Views Created with Sketch.  35K 
PTX 22/01/25 1 875
22/01/25 Last post  mrdingo Comments Created with Sketch.  1  Views Created with Sketch.  875 
PTX 22/01/25 0 405
22/01/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  405 
PTX
General information
21/01/25 35 15K
21/01/25 Last post  #lancearmstrong Comments Created with Sketch.  35  Views Created with Sketch.  15K 
PTX 13/01/25 0 534
13/01/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  534 

See All Discussions arrow Created with Sketch.

Timeline

December 2024 Quarterly Update and Appendix 4C - amended
31 Jan 15:00
 
December 2024 Quarterly Update and Appendix 4C
31 Jan 09:55
 
OmniCAR technical issues resolved and program to progress
23 Jan 09:47
 
Final Director's Interest Notice
22 Jan 15:07
 
Notification regarding unquoted securities - PTX
22 Jan 13:14
 
Notification of cessation of securities - PTX
13 Jan 09:47
 
View More arrow Created with Sketch.
(20min delay)
Last
4.9¢
Change
0.001(2.08%)
Mkt cap ! $39.46M
Open High Low Value Volume
4.9¢ 4.9¢ 4.9¢ $1.023K 20.87K

Buyers (Bids)

No. Vol. Price($)
2 89469 4.9¢
 

Sellers (Offers)

Price($) Vol. No.
5.0¢ 20000 1
View Market Depth
Last trade - 14.55pm 14/02/2025 (20 minute delay) ?
PTX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.